These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30589088)

  • 21. Sublingual-swallow immunotherapy with standardized 3-grass pollen extract: a double-blind, placebo-controlled study.
    de Blay F; Barnig C; Kanny G; Purohit A; Leynadier F; Tunon de Lara JM; Chabane H; Guérin L;
    Ann Allergy Asthma Immunol; 2007 Nov; 99(5):453-61. PubMed ID: 18051216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment.
    Rodríguez Del Río P; Vidal C; Just J; Tabar AI; Sanchez-Machin I; Eberle P; Borja J; Bubel P; Pfaar O; Demoly P; Calderón MA
    Pediatr Allergy Immunol; 2017 Feb; 28(1):60-70. PubMed ID: 27637414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five-grass pollen 300IR SLIT tablets: efficacy and safety in children and adolescents.
    Halken S; Agertoft L; Seidenberg J; Bauer CP; Payot F; Martin-Muñoz MF; Bartkowiak-Emeryk M; Vereda A; Jean-Alphonse S; Melac M; Le Gall M; Wahn U
    Pediatr Allergy Immunol; 2010 Sep; 21(6):970-6. PubMed ID: 20718927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children.
    Hamelmann E; Hammerby E; Scharling KS; Pedersen M; Okkels A; Schmitt J
    Allergy; 2024 Apr; 79(4):1018-1027. PubMed ID: 38146654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.
    Didier A; Worm M; Horak F; Sussman G; de Beaumont O; Le Gall M; Melac M; Malling HJ
    J Allergy Clin Immunol; 2011 Sep; 128(3):559-66. PubMed ID: 21802126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Importance of Tablet Formulation on Allergen Release Kinetics and Efficiency: Comparison of Freeze-dried and Compressed Grass Pollen Sublingual Allergy Immunotherapy Tablet Formulations.
    Lund K; Kito H; Skydtsgaard MB; Nakazawa H; Ohashi-Doi K; Lawton S
    Clin Ther; 2019 Apr; 41(4):742-753. PubMed ID: 30885398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen.
    Marogna M; Spadolini I; Massolo A; Berra D; Zanon P; Chiodini E; Canonica GW; Passalacqua G
    Ann Allergy Asthma Immunol; 2009 Jan; 102(1):69-75. PubMed ID: 19205289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis.
    Jerzynska J; Stelmach W; Rychlik B; Lechańska J; Podlecka D; Stelmach I
    Allergy Asthma Proc; 2016; 37(2):105-14. PubMed ID: 26932169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
    Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
    J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis.
    Dahl R; Stender A; Rak S
    Allergy; 2006 Feb; 61(2):185-90. PubMed ID: 16409194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.
    Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S
    J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of patients with respiratory allergy in France and factors influencing immunotherapy prescription: a prospective observational study (REALIS).
    Migueres M; Fontaine JF; Haddad T; Grosclaude M; Saint-Martin F; Bem David D; Crestani B
    Int J Immunopathol Pharmacol; 2011; 24(2):387-400. PubMed ID: 21658313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of sublingual immunotherapy in children aged 3-13 years with allergic rhinitis.
    Shao J; Cui YX; Zheng YF; Peng HF; Zheng ZL; Chen JY; Li Q; Cao LF
    Am J Rhinol Allergy; 2014; 28(2):131-9. PubMed ID: 24717951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis.
    Đurić-Filipović I; Caminati M; Kostić G; Filipović Đ; Živković Z
    World J Pediatr; 2016 Aug; 12(3):283-290. PubMed ID: 27351563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Developmental history of sublingual immunotherapy].
    Du W; Maekawa Y; Natsui K
    Nihon Yakurigaku Zasshi; 2019; 154(1):6-11. PubMed ID: 31308350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis.
    Pradalier A; Basset D; Claudel A; Couturier P; Wessel F; Galvain S; André C
    Allergy; 1999 Aug; 54(8):819-28. PubMed ID: 10485385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compliance in subcutaneous and sublingual allergen immunotherapy: A nationwide study.
    Borg M; Løkke A; Hilberg O
    Respir Med; 2020; 170():106039. PubMed ID: 32843170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen.
    Stelmach I; Kaczmarek-Woźniak J; Majak P; Olszowiec-Chlebna M; Jerzynska J
    Clin Exp Allergy; 2009 Mar; 39(3):401-8. PubMed ID: 19134016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in CD4+CD25+FoxP3+ Regulatory T Cells and Serum Cytokines in Sublingual and Subcutaneous Immunotherapy in Allergic Rhinitis with or without Asthma.
    Xian M; Feng M; Dong Y; Wei N; Su Q; Li J
    Int Arch Allergy Immunol; 2020; 181(1):71-80. PubMed ID: 31722337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical relevance of non-grass pollens respiratory allergies in Italy and effects of specific sublingual immunotherapy: The Rainbow Trial, a multicentre 3-year prospective observational study.
    Milani M; Pecora S;
    Eur Ann Allergy Clin Immunol; 2011 Aug; 43(4):111-6. PubMed ID: 21980798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.